I-Shiow Jan Selected Research

I-Shiow Jan Research Topics

Disease

4	Neoplasms (Cancer) 12/2021 - 09/2009
4	Disease Progression 04/2016 - 08/2005
3	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2016
3	Tuberculosis (Tuberculoses) 08/2019 - 01/2007
2	Urinary Tract Infections (Urinary Tract Infection) 03/2017 - 12/2007
2	Autoimmune Pancreatitis 09/2015 - 12/2014
2	Chronic Pancreatitis 01/2009 - 06/2007
2	Adenocarcinoma 08/2008 - 08/2005
1	Thyroid Nodule (Nodule, Thyroid) 12/2021
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Chemical and Drug Induced Liver Injury 08/2019
1	Chronic Disease (Chronic Diseases) 03/2017
1	Infections 03/2017
1	Meningeal Carcinomatosis 04/2016
1	Neurologic Manifestations (Neurological Manifestations) 04/2016
1	Lymphoma (Lymphomas) 08/2015
1	Pleural Effusion (Pleural Effusions) 02/2014
1	Lung Neoplasms (Lung Cancer) 12/2013
1	Malignant Pleural Effusion 06/2013
1	Adenocarcinoma of Lung 06/2013
1	Sepsis (Septicemia) 09/2009
1	Respiratory Insufficiency (Respiratory Failure) 09/2009
1	Pneumonia (Pneumonitis) 09/2009
1	Hypoglycemia (Reactive Hypoglycemia) 09/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2008
1	Pancreatitis 09/2007
1	Autoimmune Diseases (Autoimmune Disease) 09/2007
1	Liver Diseases (Liver Disease) 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2005

Drug/Important Bio-Agent (IBA)

2	carbazoleIBA 12/2021 - 02/2014
2	taxaneIBA 12/2021 - 04/2016
2	Bevacizumab (Avastin)FDA Link 05/2020 - 04/2016
2	Cisplatin (Platino)FDA LinkGeneric 05/2020 - 04/2016
2	Etoposide (VP 16)FDA LinkGeneric 05/2020 - 04/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2017 - 12/2007
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 09/2015 - 06/2007
2	EnzymesIBA 08/2008 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 09/2007 - 08/2005
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 08/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 08/2019
1	Mitochondrial DNA (mtDNA)IBA 08/2019
1	Pyrazinamide FDA LinkGeneric 08/2019
1	Pharmaceutical PreparationsIBA 03/2017
1	AnthracyclinesIBA 04/2016
1	Methotrexate (Mexate)FDA LinkGeneric 04/2016
1	SteroidsIBA 09/2015
1	ChromatinIBA 08/2015
1	ran-binding protein 2IBA 08/2015
1	Phosphotransferases (Kinase)IBA 08/2015
1	Kazal Pancreatic Trypsin InhibitorIBA 12/2014
1	TrypsinogenIBA 12/2014
1	RNA (Ribonucleic Acid)IBA 12/2013
1	Tyrosine Kinase InhibitorsIBA 06/2013
1	ErbB Receptors (EGF Receptor)IBA 06/2013
1	Glucose (Dextrose)FDA LinkGeneric 09/2009
1	chymotrypsin CIBA 01/2009
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2008
1	ImmunosorbentsIBA 08/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007
1	Interferon-gamma (Interferon, gamma)IBA 04/2007
1	Ferritins (Ferritin)IBA 01/2007
1	CalciumIBA 01/2007
1	Protein Isoforms (Isoforms)IBA 08/2005
1	Messenger RNA (mRNA)IBA 08/2005

Therapy/Procedure

4	Therapeutics 08/2019 - 08/2008
2	Drug Therapy (Chemotherapy) 04/2016 - 09/2009
1	Neoadjuvant Therapy 12/2021
1	Aftercare (After-Treatment) 04/2016
1	Treatment Delay 01/2007